Interaction Propensity (Tier 1)
Interaction Propensity (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. | Direction | Propensity | FDR |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_A8,13 | Lung | Primary cancer | 2,819 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.61 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A8,14 | Lung | Primary cancer | 3,301 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.67 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,15 | Lung | Primary cancer | 3,533 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.77 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,16 | Lung | Primary cancer | 3,319 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.83 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A8,17 | Lung | Primary cancer | 2,542 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.80 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A8,2 | Lung | Primary cancer | 4,657 | Stromal -> Stromal | Enriched | 5.23 | 1.32e-2 |
| NSCLC_38242124__IMC__175_A8,3 | Lung | Primary cancer | 2,796 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.97 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A8,4 | Lung | Primary cancer | 2,444 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.02 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,5 | Lung | Primary cancer | 3,198 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.40 | 1.13e-2 |
| NSCLC_38242124__IMC__175_A8,6 | Lung | Primary cancer | 5,540 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.47 | 1.44e-2 |
| NSCLC_38242124__IMC__175_A8,7 | Lung | Primary cancer | 4,852 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.70 | 1.06e-2 |
| NSCLC_38242124__IMC__175_A8,8 | Lung | Primary cancer | 2,748 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.52 | 1.58e-2 |
| NSCLC_38242124__IMC__175_A8,9 | Lung | Primary cancer | 2,887 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.77 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B1,1 | Lung | Primary cancer | 2,779 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.85 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B1,10 | Lung | Primary cancer | 2,759 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.03 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B1,11 | Lung | Primary cancer | 3,245 | Tumor/Malignant -> Tumor/Malignant | Enriched | 3.83 | 1.22e-2 |
| NSCLC_38242124__IMC__175_B1,12 | Lung | Primary cancer | 3,822 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.75 | 1.13e-2 |
| NSCLC_38242124__IMC__175_B1,13 | Lung | Primary cancer | 2,076 | Tumor/Malignant -> Tumor/Malignant | Enriched | 4.30 | 1.32e-2 |
| NSCLC_38242124__IMC__175_B1,14 | Lung | Primary cancer | 3,300 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.74 | 1.76e-2 |
| NSCLC_38242124__IMC__175_B1,15 | Lung | Primary cancer | 2,725 | Tumor/Malignant -> Tumor/Malignant | Enriched | 5.38 | 1.32e-2 |